α-Pyrrolidinoheptaphenone

From Wikipedia, the free encyclopedia
α-Pyrrolidinoheptaphenone
Alpha-Pyrrolidinoheptaphenone.svg
Clinical data
Other namesα-PHPP; alpha-PHPP; alpha-Pyrrolidinoheptiophenone; alpha-Pyrrolidinoheptanophenone; PV-8; PV8; Aphpp; A-PHPP
Legal status
Legal status
Identifiers
  • 1-Phenyl-2-pyrrolidin-1-ylheptan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC17H25NO
Molar mass259.393 g·mol−1
3D model (JSmol)
  • CCCCCC(C(=O)C1=CC=CC=C1)N2CCCC2
  • InChI=1S/C17H25NO/c1-2-3-5-12-16(18-13-8-9-14-18)17(19)15-10-6-4-7-11-15/h4,6-7,10-11,16H,2-3,5,8-9,12-14H2,1H3
  • Key:DLRWKNLMJAIFQB-UHFFFAOYSA-N

α-Pyrrolidinoheptaphenone (PV8, α-PEP, α-PHPP, Aphpp, A-PHPP) is a designer drug of the pyrrolidinophenone class of cathinones.[1][2] It is the higher homolog of α-pyrrolidinohexiophenone (α-PHP).

In the United States, α-pyrrolidinoheptaphenone is a Schedule I Controlled Substance.[3]

See also[edit]

References[edit]

  1. ^ Minakata K, Yamagishi I, Nozawa H, Hasegawa K, Wurita A, Gonmori K, et al. (2015). "Determination of new pyrrolidino cathinone derivatives, PVT, F-PVP, MPHP, PV8, PV9 and F-PV9, in human blood by MALDI-Q-TOF mass spectrometry". Forensic Toxicology. 33: 148–154. doi:10.1007/s11419-014-0248-3.
  2. ^ Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, et al. (October 2014). "Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products". Forensic Science International. 243: 1–13. doi:10.1016/j.forsciint.2014.03.013. PMID 24769262.
  3. ^ "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I". Drug Enforcement Administration.